Search for: "SmithKline Beecham Limited"
Results 141 - 160
of 160
Sorted by Relevance
|
Sort by Date
19 Nov 2009, 10:51 am
Smithkline Beecham Corp., 240 F.R.D. 179 (E.D. [read post]
11 Mar 2010, 12:23 pm
SmithKline Beecham Corp., ___ F.3d ___, 2010 WL 744273, slip op. (11th Cir. [read post]
30 Aug 2016, 2:33 pm
Smithkline Beecham Corp. [read post]
3 Jul 2008, 7:26 pm
Automobile manufacturers have been common targets for claims of intangible economic loss.We thought about including non-drug/device cases but, frankly, even we have our limits. [read post]
14 Oct 2014, 5:29 am
SmithKline Beecham Corp., 529 F.Supp. 2d 1294, 1301 & n.9 (D. [read post]
7 Feb 2007, 9:48 pm
Smithkline Beecham Corp., 2007 WL 178564, at *9 (E.D. [read post]
13 Apr 2014, 8:59 am
SmithKline Beecham [read post]
24 Jun 2010, 5:00 am
Limited fund certification rejected. [read post]
5 Aug 2021, 12:12 pm
The outcome was a vacating of the district court's grant of JMOL and a lot of discussion of drug "skinny labels": GlaxoSmithKline LLC and SmithKline Beecham (Cork) Ltd. [read post]
24 Dec 2015, 4:00 am
Each Thursday we present a significant excerpt, usually from a recently published book or journal article. [read post]
29 Aug 2008, 1:25 pm
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
19 Sep 2008, 6:00 pm
: (Techdirt), (Techdirt), Pharma & Biotech Pharma & Biotech - General Biotech patent law: eleven key pending cases and future developments to watch: (Hal Wegner), (PatentDocs) Study by The Innovation Group highlights damaging intellectual property has been to biotech: (Techdirt), Drug regulatory agencies collaborate on counterfeits, new medical products: (Intellectual Property Watch), Canada: Health Canada releases summary report on industry consultations regarding… [read post]
9 Oct 2008, 4:28 am
As we've pointed out, repeatedly, here, here, here, and here, most recent precedent has either rejected altogether the idea that uninjured people can recover prospective medical expenses, or else has limited such recoveries to environmental torts. [read post]
10 Feb 2023, 4:44 am
Putting aside the idiosyncratic chapter by the late Professor Berger, most of the third edition of the Reference Manual presented guidance on many important issues. [read post]
8 Feb 2008, 7:00 pm
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
20 Oct 2018, 8:50 am
”6 Other authors have similarly acknowledged that the need to avoid false positive results from multiple testing is an important rationale for composite end points: “Because the likelihood of observing a statistically significant result by chance alone increases with the number of tests, it is important to restrict the number of tests undertaken and limit the type 1 error to preserve the overall error rate for the trial. [read post]
27 Sep 2007, 11:38 am
Ever since the Supreme Court granted certiorari in Warner Lambert v. [read post]
3 Feb 2011, 2:11 pm
Smithkline Beecham Corp., 240 F.R.D. 179, 195 (E.D. [read post]
3 Jan 2012, 10:20 am
© Max Kennerly. [read post]
19 Sep 2013, 9:53 am
The following post is exclusively the work of the Reed Smith side of the blog.Sometimes the smallest, least significant type of lawsuit can illustrate cracks in the edifice of the largest, most consequential litigation. [read post]
